Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2016 - 2017)

Eledon Pharmaceuticals filings provide 3 years of Amortizatization of Intangibles readings, the most recent being -$1000.0 for Q1 2017.

  • On a quarterly basis, Amortizatization of Intangibles rose 97.3% to -$1000.0 in Q1 2017 year-over-year; TTM through Mar 2017 was -$79000.0, a N/A change, with the full-year FY2024 number at $359000.0, down 4.01% from a year prior.
  • Amortizatization of Intangibles hit -$1000.0 in Q1 2017 for Eledon Pharmaceuticals, up from -$6000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$1000.0 in Q1 2017 to a low of -$39000.0 in Q2 2016.
  • Median Amortizatization of Intangibles over the past 3 years was -$33000.0 (2015), compared with a mean of -$26714.3.
  • Biggest five-year swings in Amortizatization of Intangibles: changed 0.0% in 2016 and later surged 97.3% in 2017.
  • Eledon Pharmaceuticals' Amortizatization of Intangibles stood at -$38000.0 in 2015, then surged by 84.21% to -$6000.0 in 2016, then skyrocketed by 83.33% to -$1000.0 in 2017.
  • The last three reported values for Amortizatization of Intangibles were -$1000.0 (Q1 2017), -$6000.0 (Q4 2016), and -$33000.0 (Q3 2016) per Business Quant data.